Ledger.Open graph →
SEC Form D · filed August 18, 2015

Pelican Therapeutics, Inc

Offering
$1.0M
Sold
$250K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
AUSTIN, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Jeffrey Wolf · Durham, NCDirectorEdward B. Smith · New York, NYDirectorTaylor Schreiber · Durham, NCDirectorChristopher W. Keller · Chicago, ILDirectorAloysius Fobi · Portland, ORDirectorRahul Jasuja · Boca Raton, FLDirectorJosiah Hornblower · San Francisco, CAExec · DirectorJani Teeter · Old Bridge, NJDirectorMichael T. Sicoli · McLean, VADirectorRahul Jasuja · Boca Raton, FLDirectorJosiah Hornblower · Austin, TXExec · DirectorTaylor Schreiber · Durham, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗